Paper34711990
Direct targeting of amplified gene loci for proapoptotic anticancer therapy.
Kaushik Tiwari M and 11 others. Nat Biotechnol, 2022. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Direct targeting of amplified gene loci for proapoptotic anticancer therapy. Papers, record 34711990. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34711990
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Gene Amplification | Major topic |
| DNA Damage | |
| Female | |
| Genomics | |
| Humans | |
| Oligonucleotides |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 GM126211 | NIGMS NIH HHS | United States | R01GM126211 | PubMed and NIH | NIH RePORTER |
| R21 CA185192 | NCI NIH HHS | United States | R21CA185192 | PubMed and NIH | NIH RePORTER |
| T32 GM136651 | NIGMS NIH HHS | United States | T32GM136651 | PubMed | NIH RePORTER |
| R01CA149128 | NIH | NIH RePORTER | |||
| T32GM007205 | NIH | NIH RePORTER | |||
| T32GM007223 | NIH | NIH RePORTER |
References2
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7585609 | ERBB-2 (HER2/neu) gene copy number, p185HER-2 overexpression, and intratumor heterogeneity in human breast cancer. | Cancer Res | 1995 | https://conductscience.org/library/papers/7585609 | PubMed |
| 2 | 11406568 | Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. | Cancer Res | 2001 | https://conductscience.org/library/papers/11406568 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42492518 | Self-sufficient killing of malignant tumors by an engineered cancer-selective gene circuit. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42492518 | PubMed |
| 42385711 | Targeted DNA triplex-forming oligonucleotide liposome for pulmonary fibrosis gene therapy. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42385711 | PubMed |
| 41127334 | Cell-penetrating antibody enhances nuclear delivery of triplex-forming oligonucleotides targeting HER2-positive cancers. | Mol Ther Nucleic Acids | 2025 | https://conductscience.org/library/papers/41127334 | PubMed |
| 40506395 | Efficacy of DNA Intercalator-Conjugated Triplex-Forming Oligonucleotide as Anticancer Agent. | ChemMedChem | 2025 | https://conductscience.org/library/papers/40506395 | PubMed |
| 40319546 | Weaponizing CRISPR/Cas9 for selective elimination of cells with an aberrant genome. | DNA Repair (Amst) | 2025 | https://conductscience.org/library/papers/40319546 | PubMed |
| 39843926 | Development and functional evaluation of a psoralen-conjugated nucleoside mimic for triplex-forming oligonucleotides. | Commun Chem | 2025 | https://conductscience.org/library/papers/39843926 | PubMed |
| 39223307 | Chemoproteomic profiling unveils binding and functional diversity of endogenous proteins that interact with endogenous triplex DNA. | Nat Chem | 2024 | https://conductscience.org/library/papers/39223307 | PubMed |
| 38661214 | TTSBBC: triplex target site biomarkers and barcodes in cancer. | Nucleic Acids Res | 2024 | https://conductscience.org/library/papers/38661214 | PubMed |
| 38019857 | Adaptive DNA amplification of synthetic gene circuit opens a way to overcome cancer chemoresistance. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/38019857 | PubMed |
| 37896275 | Recent Advancements in Development and Therapeutic Applications of Genome-Targeting Triplex-Forming Oligonucleotides and Peptide Nucleic Acids. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37896275 | PubMed |
| 37850170 | Label-Free Virtual HER2 Immunohistochemical Staining of Breast Tissue using Deep Learning. | BME Front | 2022 | https://conductscience.org/library/papers/37850170 | PubMed |
| 37630183 | Surface Characteristics Affect the Properties of PLGA Nanoparticles as Photothermal Agents. | Micromachines (Basel) | 2023 | https://conductscience.org/library/papers/37630183 | PubMed |
| 37468837 | Nanoparticle delivery of TFOs is a novel targeted therapy for HER2 amplified breast cancer. | BMC Cancer | 2023 | https://conductscience.org/library/papers/37468837 | PubMed |
| 37108234 | In Vitro and In Vivo Effects of the Combination of Polypurine Reverse Hoogsteen Hairpins against HER-2 and Trastuzumab in Breast Cancer Cells. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108234 | PubMed |
| 36817975 | Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy. | Regen Biomater | 2023 | https://conductscience.org/library/papers/36817975 | PubMed |
| 36618947 | Triplex-forming oligonucleotides as an anti-gene technique for cancer therapy. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36618947 | PubMed |
| 35359341 | KIF26B in the Prognosis and Immune Biomarking of Various Cancers: A Pan-Cancer Study. | J Oncol | 2022 | https://conductscience.org/library/papers/35359341 | PubMed |
| 35355264 | Unravelling the tumour genome: The evolutionary and clinical impacts of structural variants in tumourigenesis. | J Pathol | 2022 | https://conductscience.org/library/papers/35355264 | PubMed |
| 34837080 | Amplifying targeting. | Nat Rev Cancer | 2022 | https://conductscience.org/library/papers/34837080 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34711990
GET https://conductscience.org/api/papers/v1/34711990/authors